PROTHENA CORP PUBLIC LTD CO
For the period ended Dec 31, 2024. Filed Feb 27, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 27, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Power of Attorney (see signature page hereto)
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose individual signature appears below hereby authorizes and appoints Gene G. Kinney and Tran B. Nguyen, and each of them, with full power of substitution and resubstitution and full power to act without the other, as his or her true and lawful attorney-in-fact and agent to act in his or her name, place and stead and to execute in the name and on behalf of each person, individually and in each capacity stated below, and to file any and all amendments to this Annual Report on Form 10-K, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing, ratifying and confirming all that said attorneys-in-fact and agents or any of them or their or his substitute or substitutes may lawfully do or cause to be done by virtue thereof.
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.
| Name | Title | Date |
|---|---|---|
| /s/ Gene G. Kinney | President and Chief Executive Officer | February 27, 2025 |
| Gene G. Kinney, Ph.D. | (Principal Executive Officer) and Director | |
| /s/ Tran B. Nguyen | Chief Strategy Officer and Chief Financial Officer | February 27, 2025 |
| Tran B. Nguyen | (Principal Financial Officer) | |
| /s/ Karin L. Walker | Chief Accounting Officer | February 27, 2025 |
| Karin L. Walker | (Principal Accounting Officer) | |
| /s/ Daniel G. Welch | Chair of the Board | February 27, 2025 |
| Daniel G. Welch | ||
| /s/ Paula K. Cobb | Director | February 27, 2025 |
| Paula K. Cobb | ||
| /s/ Richard T. Collier | Director | February 27, 2025 |
| Richard T. Collier | ||
| /s/ Shane M. Cooke | Director | February 27, 2025 |
| Shane M. Cooke | ||
| /s/ William H. Dunn, Jr. | Director | February 27, 2025 |
| William H. Dunn, Jr., M.D. | ||
| /s/ Lars G. Ekman | Director | February 27, 2025 |
| Lars G. Ekman, M.D., Ph.D. | ||
| /s/ Helen S. Kim | Director | February 27, 2025 |
| Helen S. Kim | ||
| /s/ Dennis J. Selkoe | Director | February 27, 2025 |
| Dennis J. Selkoe, M.D. | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.